A "normal" mammogram interpreted by AI can accurately forecast high-risk of breast cancer in the next 5 years. Approved by FDA, now becoming available. But it should be free and part of every mammogram readout. Front page @nytimes.com today, www.nytimes.com/2026/10/01/w...

Women Can Now Assess Their Breast Cancer Risk With the Help of A.I. (Gift Article)

Clairity Breast, an A.I. tool that can predict five-year risk of developing breast cancer, is rolling out nationwide. Here’s what experts want you to know.

nytimes.com

A team of researchers at MCW found that clonazepam, which kills parasitic worms, also activates cold sensing in humans. This means the drug may treat the oral pain experienced by many chemotherapy patients. Learn more: www.mcw.edu/mcwknowledge...

In 2024, we published 'Reablement, Rehabilitation, Recovery: Everyone’s business', our report which sets out what high-quality rehabilitation for older people with frailty looks like, and how it should be delivered. Read the report to learn more: buff.ly/UWXiHNQ #RehabAwarenessWeek #RightToRehab

Updated ASCO Guideline: Systemic Therapy in Patients w/ Metastatic Castration-Resistant Prostate Cancer. Including evidence from prev. trials along w/ 2 additional trials & updates algorithms for biomarker-informed treatment selection. Read the guideline: https://bit.ly/3UTCkT5

Why have antioxidant supplements not helped reduce the incidence of cancer and in some trials shown an increase? Suppression of T cell immune response to cancer @ScienceMagazine science.org/doi/10.1126/... science.org/doi/10.1126/...

@ascocancer.bsky.social While ASCO guideline recommends risk-based surveillance, regular oncology visits offer substantial psychological comfort independent of risk status. Early integration of palliative care can bridge this transition, addressing patient fears and frets. @drjunejd.bsky.social

American Society of Clinical Oncology@ascocancer.bsky.social · last mo.

What’s the optimal follow-up visit schedule for patients with #breastcancer? The latest ASCO guideline update recommends a risk-based approach. See the highlights in #ASCODailyNews: https://bit.ly/4xwJoUh

The BGS is launching a new clinical journal, Age and Ageing Advances. We are seeking a founding Editor-in-Chief, a rare opportunity to lead the journal's vision, editorial standards and scientific influence from its inception. Take a look and see if the role is for you: buff.ly/s1uwnZT

Editor-In-Chief of Age and Ageing Advances journal | British Geriatrics Society

The British Geriatrics Society (BGS) is seeking an exceptional Editor-in-Chief (EiC) to lead the launch of a new medical journal.

bgs.org.uk

Deconditioning is a major and preventable contributor to loss of independence among older adults. Our Deconditioning Hub has been created to help members improve outcomes for older people by identifying and preventing deconditioning. buff.ly/94JBnqS

Deconditioning Hub | British Geriatrics Society

We have created this hub to support our members to improve outcomes for older people through the identification and prevention of deconditioning.

bgs.org.uk

We need to rev it up. Cancer vaccines. nature.com/articles/d41... @nature.com

Thanks for your immense contributions. RIP Dr Freeman! @drjunejd.bsky.social

American Society of Clinical Oncology@ascocancer.bsky.social · 2mo ago

ASCO mourns the passing of Dr. Harold P. Freeman, the “father of patient navigation,” and honors his tireless advocacy for health equity. Read more: https://bit.ly/3Up67CN

This peptide craze is dangerous and is outpacing scientific evidence. Social media influencers should not trump scientists! @drjunejd.bsky.social

Eric Topol@erictopol.bsky.social · 2mo ago

The dangers of RFK Jr's peptide push Example: "If you have a few precancerous cells lurking indolently in your prostate or breast, injecting a peptide that stimulates human growth hormone might supercharge them into a tumor." gift link wapo.st/4wycy3O

Stop the hype on anti-aging treatments such as NAD+ and peptides. Get the evidence. Editorial @naturemedicine.bsky.social nature.com/articles/s41...

New BGS report: Optimising the impact of geriatricians Health and care systems across the UK are facing sustained workforce constraints at the same time as demand from an ageing population continues to rise. buff.ly/qtWzknL

🎙#EdBook Editor-in-Chief Dr. Gerald Hsu & Dr. Martin Dreyling discuss the latest clinical data in mantle cell lymphoma, maintenance strategies, and the future role of chemo-free & IO in #MCL on the #ByTheBook Podcast - https://bit.ly/4hsS6xI #HemOnc #Lymphoma

Advance your pharmacology expertise in hospice and palliative care. Register for AAHPM's Sept. 15 virtual workshop and save 10% with code PHARMA26 through Aug. 4. https://ow.ly/6UkE50Zu075

Our (Schoen MW, McKoy JM, Bennett CL) invited commentary is now published; see JAMA Netw Open at jamanetwork.com/journals/jaman… @drjunejd.bsky.social @jamanetworkopen.com

Dr. Fiorella Iglesias Cardenas provides helpful guidance for early-career investigators looking to intentionally and meaningfully engage with the National Clinical Trials Network. Read more: https://bit.ly/4pkfkYu #ASCOConnection

The 2027 Medicare Physician Fee Schedule and Quality Payment Program proposed rule is out now. We’re analyzing the impact on cancer care, but an initial estimate shows a 1.5% overall reimbursement cut for hematology/oncology Learn more: https://bit.ly/456jTfH #ASCOAdvocacy

The stories of MCW-Green Bay alumni illustrate how MCW has become a national leader and role model for immersive, community-based medical programs that retain physician talent. Learn more: www.mcw.edu/mcwknowledge...

In Green Bay, Alumni Have Become ‘Part of the Community’

Over the past decade, MCW-Green Bay alumni have stayed in the area to practice medicine and help train the next generation of physicians.

mcw.edu

Mentorship matters! Happy to “catchup” on the progress of my wonderful mentee, Fares Siddig, a rising M2 @columbiaup.bsky.social Vagelos College of Physicians and Surgeons. I’m quite proud of him! This is one of my primary reasons for remaining in academic medicine @drjunejd.bsky.social

Ready to guide the future of oncology? Applications are open for our 2027-28 ASCO Leadership Development Program (LDP)! Transform into a next-gen leader through a 1-year immersive curriculum with mentorship, expert training, and a great group of peers. Apply now: https://bit.ly/44a2fYd

MCW’s Dr. Anai Kothari joined WUWM 89.7 to discuss how #AI is being used as a tool in medical research to tackle real-world problems in #Wisconsin. Learn more: www.wuwm.com/ai-healthcar...

How AI is shaping medical research in Wisconsin

AI can speed up tedious medical research tasks. But it also makes mistakes and raises privacy concerns too. How can it be used responsibly?

wuwm.com

Dr Eric Baeuerle MD PhD and I @drjunejd.bsky.social are thrilled to share our @medicalcollegeofwi.bsky.social Geriatric Fast Casts on “Older Adult Representation in Clinical Trials” at podcasts.apple.com/us/podcast/g...

Our Oncogeriatrics elearning course specifically focuses on the unique needs and circumstances of older people with cancer. This course has been developed with input from across the multidisciplinary team, so it has a lot to offer. Sign up here: buff.ly/kNVjOSH

End of Life Care in Frailty - This guidance has been produced to support clinicians and others in providing high-quality care for older people living with frailty as they move towards the end of their lives.  Read the full guidance here: buff.ly/1iRd8VS

Advance Care Planning: A Patient Journey is a short Microlearning CDP course from the BGS. It's totally free for our members, and available at a small cost for non-members. #ACPDay2026 buff.ly/L8isfFb

Ovarian cancer often responds poorly to immunotherapy. MCW researcher Pradeep Chaluvally-Raghavan is working to understand the molecular mechanism behind this phenomenon – an effort that may result in better immunotherapies. Learn more: www.mcw.edu/mcwknowledge...

Hot on the Trail of Cold Tumors

How MCW researcher Pradeep Chaluvally-Raghavan went from curious student to cutting-edge cancer researcher.

mcw.edu

We honor the memory of Dr. Maura L. Gillison, a 2021 ASCO Karnofsky Award recipient. Her landmark research establishing the link between HPV & oral cancer fundamentally changed modern oncology.

ASCO Remembers Karnofsky Award Recipient Dr. Maura L. Gillison, Pioneer in HPV-Associated Cancers

ASCO Connection is the official member publication for members of the American Society of Clinical Oncology and the Association for Clinical Oncology.

connection.asco.org

What an amazing year! It was challenging juggling faculty research work (data collection/analytics and publications) AND training but I did it! Along the way I’ve met amazing colleagues and now friends like APP Lisa Bullis @medicalcollegeofwi.bsky.social So much more to come @drjunejd.bsky.social

Discovery of a 14-protein biomarker that predicts lung cancer 5.6 years before it is diagnosed, even in non-smokers, and an anti-inflammatory medicine that prevents its progression. And, challenging dogma, the proteins are not coming from cancerous cells!